Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Been here a while lurking

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Nov 09, 2022 3:57pm

114 Views

Post# 35086402

RE:RE:RE:RE:Been here a while lurking

I'm just hoping there is no update that says we pushed everything out by X months for whatever reasons. The science seems to be solid and the doctors and scientists behind this seem to be solid as well. I just wish there was better and timely communications and good execution to build confidence and trust in that solid core. If anyone else thinks they're doing a wonderful job, fine by me. It's an opinion on a message board. I'm just hoping they stick to the Q4 submission milestone.

<< Previous

Bullboard Posts

Next >>

Critical raw materials pioneer drives Europe’s clean energy transition